United States reverse payment settlementsrule of reasonhatch waxman

Federal Trade Commission v Actavis Inc

570 U.S. 136 (2013)

JurisdictionUnited States

CourtSupreme Court of the United States

Year2013

StatusBinding authority

Key Principle

Reverse payment patent settlements between brand-name and generic drug manufacturers are subject to antitrust scrutiny under the rule of reason.

competition

US v Google LLC (Search Antitrust) No. 1:20-cv-03010 (D.D.C. 2024)

Epic Games Inc v Apple Inc (Supreme Court) Nos. 23-337 and 23-344 (cert. denied Jan. 16, 2024)

Epic Games Inc v Apple Inc 67 F.4th 946 (9th Cir. 2023)

Get a detailed analysis of Federal Trade Commission v Actavis Inc and how it applies to your situation.